Lugen Zuo

1.8k total citations
93 papers, 1.4k citations indexed

About

Lugen Zuo is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Lugen Zuo has authored 93 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Genetics, 26 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Lugen Zuo's work include Inflammatory Bowel Disease (48 papers), Gut microbiota and health (15 papers) and Microscopic Colitis (11 papers). Lugen Zuo is often cited by papers focused on Inflammatory Bowel Disease (48 papers), Gut microbiota and health (15 papers) and Microscopic Colitis (11 papers). Lugen Zuo collaborates with scholars based in China, Australia and United States. Lugen Zuo's co-authors include Jieshou Li, Lili Gu, Jianfeng Gong, Weiming Zhu, Weiming Zhu, Zhen Guo, Jie Zhao, Jianning Dong, Lei Cao and Ning Li and has published in prestigious journals such as Oncogene, The FASEB Journal and Biochemical Pharmacology.

In The Last Decade

Lugen Zuo

86 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lugen Zuo China 22 581 469 374 358 243 93 1.4k
Raquel Franco Leal Brazil 18 567 1.0× 325 0.7× 357 1.0× 377 1.1× 297 1.2× 95 1.4k
Györgyi Műzes Hungary 23 350 0.6× 643 1.4× 188 0.5× 340 0.9× 344 1.4× 94 1.7k
Gilles Laverny France 19 231 0.4× 627 1.3× 401 1.1× 313 0.9× 349 1.4× 38 1.8k
Shunsuke Komoto Japan 23 250 0.4× 391 0.8× 359 1.0× 219 0.6× 305 1.3× 80 1.3k
Fumitoshi Watanabe Japan 15 840 1.4× 180 0.4× 359 1.0× 545 1.5× 324 1.3× 36 1.5k
Isabelle Frey‐Wagner Switzerland 18 250 0.4× 714 1.5× 199 0.5× 230 0.6× 314 1.3× 33 1.3k
Monica T. Midura‐Kiela United States 18 254 0.4× 558 1.2× 189 0.5× 100 0.3× 232 1.0× 31 1.2k
Yoshikiyo Okada Japan 25 209 0.4× 692 1.5× 307 0.8× 365 1.0× 325 1.3× 73 1.7k
Yasuhiko Maruyama Japan 15 515 0.9× 157 0.3× 405 1.1× 343 1.0× 133 0.5× 40 1.2k
Zhiming Huang China 23 162 0.3× 713 1.5× 246 0.7× 335 0.9× 381 1.6× 71 1.7k

Countries citing papers authored by Lugen Zuo

Since Specialization
Citations

This map shows the geographic impact of Lugen Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lugen Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lugen Zuo more than expected).

Fields of papers citing papers by Lugen Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lugen Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lugen Zuo. The network helps show where Lugen Zuo may publish in the future.

Co-authorship network of co-authors of Lugen Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Lugen Zuo. A scholar is included among the top collaborators of Lugen Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lugen Zuo. Lugen Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lian, Zhen Zhang, Xiaohua Chen, et al.. (2025). Sakuranetin ameliorates experimental colitis in a gut microbiota-dependent manner. Phytomedicine. 139. 156540–156540. 4 indexed citations
2.
Li, Jing, Zhijun Geng, Lixia Yin, et al.. (2025). Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway. Frontiers in Pharmacology. 15. 1496068–1496068. 2 indexed citations
3.
Wang, Mengyang, Yuwu Chen, Bi-Yi Xu, et al.. (2025). Recent advances in the roles of extracellular vesicles in cardiovascular diseases: pathophysiological mechanisms, biomarkers, and cell-free therapeutic strategy. Molecular Medicine. 31(1). 169–169. 3 indexed citations
4.
5.
Geng, Zhijun, et al.. (2024). Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling. The FASEB Journal. 38(14). e23817–e23817. 11 indexed citations
6.
Song, Xue, Xiaofeng Zhang, Min Zhang, et al.. (2024). The JNK/P38 signalling pathway activated by testin protects the intestinal epithelial barrier against Crohn's disease-like colitis. Chemico-Biological Interactions. 403. 111222–111222. 1 indexed citations
7.
8.
Zhu, Guo‐Qing, Xue Song, Zhiyuan Wang, et al.. (2023). Esculentoside A ameliorates BSCB destruction in SCI rat by attenuating the TLR4 pathway in vascular endothelial cells. Experimental Neurology. 369. 114536–114536. 1 indexed citations
9.
10.
11.
Yang, Cheng, Jing Li, Lian Wang, et al.. (2023). Eriocalyxin B ameliorated Crohn's disease-like colitis by restricting M1 macrophage polarization through JAK2/STAT1 signalling. European Journal of Pharmacology. 954. 175876–175876. 9 indexed citations
12.
Zuo, Lugen, et al.. (2022). Evaluation of Health Information Literacy of Rural Community Residents Based on Intuitionistic Fuzzy Set Multicriteria. Mathematical Problems in Engineering. 2022. 1–9. 1 indexed citations
13.
Tian, Yun, et al.. (2022). Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice. Nutrition. 102. 111712–111712. 8 indexed citations
14.
Zhang, Xiaofeng, Guangyong Liu, Yiran Liu, et al.. (2022). Ruscogenins Improve CD‐Like Enteritis by Inhibiting Apoptosis of Intestinal Epithelial Cells and Activating Nrf2/NQO1 Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 4877275–4877275. 17 indexed citations
15.
Li, Jing, Lugen Zuo, Zhijun Geng, et al.. (2022). Pygopus2 ameliorates mesenteric adipocyte poor differentiation to alleviate Crohn's disease ‐like colitis via the Axin2/GSK3β pathway. Cell Proliferation. 55(10). e13292–e13292. 7 indexed citations
16.
Song, Xue, Lugen Zuo, Zhijun Geng, et al.. (2021). Epac‐2 ameliorates spontaneous colitis in Il‐10−/− mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling. Journal of Cellular and Molecular Medicine. 26(1). 216–227. 12 indexed citations
17.
Ge, Yuanyuan, Yi Li, Qin Chen, et al.. (2018). Adipokine apelin ameliorates chronic colitis in Il-10−/− mice by promoting intestinal lymphatic functions. Biochemical Pharmacology. 148. 202–212. 42 indexed citations
18.
Zhao, Jie, Ye Sun, Peiliang Shi, et al.. (2015). Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy. International Immunopharmacology. 26(1). 221–228. 69 indexed citations
19.
Wang, Honggang, Jianning Dong, Peiliang Shi, et al.. (2014). Anti‐mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin‐10 knockout mice with spontaneous chronic colitis. Immunology. 144(2). 254–262. 19 indexed citations
20.
Wang, Hong‐Gang, Wei Zhang, Lugen Zuo, et al.. (2012). Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. British Journal Of Nutrition. 109(11). 1990–1998. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel Franco Leal Breakdown of academic impact, for papers by Györgyi Műzes Breakdown of academic impact, for papers by Gilles Laverny Breakdown of academic impact, for papers by Shunsuke Komoto Breakdown of academic impact, for papers by Fumitoshi Watanabe Breakdown of academic impact, for papers by Isabelle Frey‐Wagner Breakdown of academic impact, for papers by Monica T. Midura‐Kiela Breakdown of academic impact, for papers by Yoshikiyo Okada Breakdown of academic impact, for papers by Yasuhiko Maruyama Breakdown of academic impact, for papers by Zhiming Huang
Rankless by CCL
2026